Pulse of the Hill

The Definitive Fly-In Directory

AboutAlertsAdd Your Fly-InSign in

Bill Detail

S. 1095

Congress: 119

Title

Stop STALLING Act

Summary

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit is subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

Sponsor

Sen. Amy Klobuchar [D-MN]

Status

Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.

Status as of Jun 29, 2:24 AM · synced 18h ago

Introduced

2025-03-24

Open on Congress.govCongress.gov searchBack to directory

Data source mode: cache

Bill Engagement

Lobbyists on the case

6 orgs · 77 lobbyists · 13 filings mention S. 1095 (Stop STALLING Act) in LDA disclosures.